Bromocriptine to Treat Portal Systemic Encephalopathy

  • M. Uribe


The clinical spectrum of portal systemic encephalopathy (PSE) is very wide. It may occur as a subclinical form, sometimes only detected by the electroencephalogram, frequently occurs as acute or chronic recurrent syndrome (spontaneous or induced by gastrointestinal bleeding, diuretics, sepsis, etc.), and as a rare form in which neurologicalrather than hepatic signs are predominant, these groups of patients represent chronic hepatocerebral degeneration.1


Hepatic Encephalopathy Control Period Ergot Alkaloid Double Blind Fashion Lysergic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. M. Hoyumpa, P.V, Desmond, and G. R. Avanti, Hepatic encephalopathy, Gastroenterology 76: 184 (1979).PubMedGoogle Scholar
  2. 2.
    M. Lunzer, I. M. James, and R. Weinman, Treatment of chronic hepatic encephalopathy with levodopa, Gut 15: 555 (1974).PubMedCrossRefGoogle Scholar
  3. 3.
    H. Michel, H. Solere, and P. Gravier, Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial, Gastroenterology 79: 207 (1980).PubMedGoogle Scholar
  4. 4.
    Y. M. Morgan, A. Jocobovitz, and A. Ellithorn, Successful use of bromocriptine in the treatment of a patient with chronic portal systemic encephalopathy, N. Engl. J. Med. 296: 793 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Uribe, A. Farca, and M. A. Marquez, Treatment of chornic portal systemic encephalopathy with bromocriptine. A double blind controlled trial, Gastroenterology 76: 1347 (1979).PubMedGoogle Scholar
  6. 6.
    M. Messner, P. Brissot, and P. Toulouse, Comparison of bromocriptine and lactulose in the treatment of spontaneous chronic portal systemic encephalopathy, Hepatology, in press (1983).Google Scholar
  7. 7.
    J, Ubiria, M. Morales, and M. Vila, Tratamiento de la encefalopatia crònica portosistémica con bromocriptina, Rev. Esp. Enf. Ap. Digest. 58: 21 (1980).Google Scholar
  8. 8.
    M. Uribe, M. A. Màrquez, and L. Guevara, Bromocriptine for severe chronic portal systemic encephalopathy, Gastroenterology 82: 1201 (1982).Google Scholar
  9. 9.
    P. Granier, G. Cauvet, and G. Guilleret, A propos du traitment de l’encephalopathie hepatique par la bromocriptine, Gastroenterologie Clin. Biol. 3: 210 (1979).Google Scholar
  10. 10.
    M. Y. Morgan, A. W. Jacobovitz, and T. M. James, Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy, Gastroenterology 78: 667 (1980).Google Scholar
  11. 11.
    M. Uribe, A. Ballesteros, and J. Rosales, Do dopamine antagonist drugs induce hepatic encephalopathy? Hepatology 2: 746 (Abst. H/293) (1982).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • M. Uribe
    • 1
  1. 1.Instituto Nacional de la Nutriciòn Salvador Zubiràn Liver UnitMexico D.F.Mexico

Personalised recommendations